Sanjivani Paranteral Ltd

NSE: SANJIVIN · BSE: 531569 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹176.50
Market cap: ₹216.8 Cr
Revenue (annual): ₹68.67 Cr
Net profit (annual): ₹6.79 Cr
P/E (TTM): 20.6×Sector 47.3×
Promoter holding: 31.56%+0.30% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Fund Raise 2 Board Meeting Date 2 Results Update 1 Other Announcement 1 Financial Results 1 Earnings Call 1 Capital Structure Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Aug 2026 16:20 IST BSE

Results Update

Sanjivani Paranteral Results Update

Sanjivani Paranteral reported Q1 FY27 results, with total income of ₹23.99 Crore and a net profit of ₹2.49 Crore. The company demonstrated strong year-on-year growth across key metrics.

Read the filing ↗